Schenkein David P

Average Profitability
29.7%
Insider Buys Quantity
2
Insider Buys Sum
$449,904.00
Insider Sells Quantity
65
Insider Sells Sum
$68.16M

Insider Activity of Schenkein David P

According to the SEC Form 4 filings, Schenkein David P, being in a position of

  1. director at Agios Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 137471 share for $4.66M,
    over all time since 2014-07-01, has bought 8064 shares for $249,984, and sold 937859 shares for $59.59M.

The largest purchase of all time was on 2019-11-13 and amounted to 8064 shares of Agios Pharmaceuticals, Inc. for $249,984.

The largest sale of all time was on 2017-10-04 and amounted to 80000 shares of Agios Pharmaceuticals, Inc. for $5.61M.

Biography of Schenkein David P

No biography is available at this moment.

2024-11-11SaleDenali Therapeutics Inc.
DNLI
director
59,441
0.0421%
$32.51$1.93M-22.45%
2024-02-27SaleAgios Pharmaceuticals, Inc.
AGIO
director
69,329
0.1786%
$34.67$2.4M+25.8%
2024-02-26SaleAgios Pharmaceuticals, Inc.
AGIO
director
20,411
0.0503%
$33.19$677,441+33.08%
2024-02-23SaleAgios Pharmaceuticals, Inc.
AGIO
director
47,731
0.1172%
$33.05$1.58M+32.46%
2023-04-03SaleAgios Pharmaceuticals, Inc.
AGIO
director
16,363
0.0298%
$22.85$373,895+11.81%
2023-03-27SaleAgios Pharmaceuticals, Inc.
AGIO
director
20,000
0.036%
$22.15$443,000+12.83%
2023-03-13SaleAgios Pharmaceuticals, Inc.
AGIO
director
20,000
0.036%
$22.49$449,817+8%
2023-02-27SaleAgios Pharmaceuticals, Inc.
AGIO
director
20,000
0.0363%
$25.37$507,400-4.91%
2023-02-13SaleAgios Pharmaceuticals, Inc.
AGIO
director
20,000
0.0358%
$28.62$572,400-16.91%
2023-01-30SaleAgios Pharmaceuticals, Inc.
AGIO
director
20,000
0.0364%
$29.33$586,578-16.38%
2023-01-17SaleAgios Pharmaceuticals, Inc.
AGIO
director
20,000
0.0366%
$28.85$577,093-13.15%
2020-12-21SaleDenali Therapeutics Inc.
DNLI
director
30,000
0.0248%
$90.05$2.7M-38.96%
2020-11-12SaleDenali Therapeutics Inc.
DNLI
director
30,000
0.025%
$70.05$2.1M-12.79%
2020-11-10SaleDenali Therapeutics Inc.
DNLI
director
10,000
0.0083%
$60.03$600,310+1.93%
2020-11-04SaleDenali Therapeutics Inc.
DNLI
director
10,000
0.0081%
$50.18$501,830+18.56%
2019-11-13PurchaseAgios Pharmaceuticals, Inc.
AGIO
director
8,064
0.0121%
$31.00$249,984+28.93%
2018-06-01SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Executive Officer
13,000
0.0222%
$95.35$1.24M-32.73%
2018-05-30SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Executive Officer
45,626
0.0789%
$90.07$4.11M-27.51%
2018-05-23SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Executive Officer
49,374
0.087%
$90.40$4.46M-26.01%
2018-05-01SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Executive Officer
13,000
0.0223%
$83.04$1.08M-19.49%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.